Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 172 | 79 | 0 |
Full Text Views | 5 | 2 | 0 |
PDF Downloads | 5 | 3 | 0 |
Hemagglutination-inhibiting antibody responses with selected Group B arthropod-borne virus antigens were studied following administration of living attenuated 17D strain yellow fever vaccine to human subjects who had (a) no previous Group B arbovirus experience, (b) only 17D strain vaccine previously, (c) previous inapparent natural Japanese encephalitis virus infection and (d) complex Group B arbovirus experience previously. The results indicate the following:
Trainee in Virology, Training Grant No. 2E-16, N.I.H. (U.S.P.H.S.). Currently, Chief of the Serology Section, Department of Microbiology.